ABOS - Acumen Pharmaceuticals, Inc. -  [ ]

Ticker Details
Acumen Pharmaceuticals, Inc.
IPO Date: July 1, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $181.29M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.18 | 3.77%
Avg Daily Range (30 D): $0.07 | 2.81%
Avg Daily Range (90 D): $0.10 | 3.75%
Institutional Daily Volume
Avg Daily Volume: .37M
Avg Daily Volume (30 D): .3M
Avg Daily Volume (90 D): .68M
Trade Size
Avg Trade Size (Sh.): 123
Avg Trade Size (Sh.) (30 D): 97
Avg Trade Size (Sh.) (90 D): 122
Institutional Trades
Total Institutional Trades: 60
Avg Institutional Trade: $2.13M
Avg Institutional Trade (30 D): $1M
Avg Institutional Trade (90 D): $1M
Avg Institutional Trade Volume: .39M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.31M
Avg Closing Trade (30 D): $3.8M
Avg Closing Trade (90 D): $3.8M
Avg Closing Volume: 640.1K
 
News
May 12, 2026 @ 11:00 AM
Acumen Pharmaceuticals Reports First Quarter 2026 ...
Source: Acumen Pharmaceuticals, Inc.
May 7, 2026 @ 8:00 PM
Acumen Pharmaceuticals to Participate in the Bank ...
Source: Na
May 5, 2026 @ 8:00 PM
Acumen Pharmaceuticals to Report First Quarter Fin...
Source: Na
Mar 19, 2026 @ 8:00 PM
Acumen Pharmaceuticals to Report Fourth Quarter an...
Source: Na
Mar 10, 2026 @ 8:00 PM
Acumen Pharmaceuticals to Participate in the Stife...
Source: Na
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-.33 $-.41 $-2
Diluted EPS $-.33 $-.41 $-2
Revenue $M $M $M
Gross Profit
Net Income / Loss $-20.74M $-25.14M $-121.34M
Operating Income / Loss $-21.15M $-25.2M $-123.83M
Cost of Revenue
Net Cash Flow $-2.19M $7.16M $18.36M
PE Ratio